Urethral Clear Cell Adenocarcinoma
specificA morphologic variant of urethral adenocarcinoma characterized by the presence of tubulocystic or papillary structures lined with clear cuboidal or hobnail cells.
37
Centers
37
Active Trials
—
Cancer Funding
Top Centers for Urethral Clear Cell Adenocarcinoma(37)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 51.4 |
| 2 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 51.4 |
| 3 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 51.4 |
| 4 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 51.4 |
| 5 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 51.4 |
| 6 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 51.4 |
| 7 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 51.4 |
| 8 | NCI Comprehensive Active Research Program | 51.4 |
| 9 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 51.4 |
| 10 | NCI Comprehensive Active Research Program | 51.4 |
| 11 | NCI Comprehensive Active Research Program | 51.4 |
| 12 | NCI Comprehensive Active Research Program | 51.4 |
| 13 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 51.4 |
| 14 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 51.4 |
| 15 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 51.4 |
| 16 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 51.4 |
| 17 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 51.4 |
| 18 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 51.4 |
| 19 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 51.4 |
| 20 | NCI Clinical Active Research Program | 51.4 |
| 21 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 51.4 |
| 22 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 51.4 |
| 23 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program | 51.4 |
| 24 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 51.4 |
| 25 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 51.4 |
| 26 | University of Illinois Cancer CenterChicago, IL Active Research Program | 51.4 |
| 27 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 51.4 |
| 28 | Cancer Center at IllinoisUrbana, IL Active Research Program | 51.4 |
| 29 | Penn State Cancer InstituteHershey, PA Active Research Program | 51.4 |
| 30 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 51.4 |
| 31 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 51.4 |
| 32 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 51.4 |
| 33 | Active Research Program | 51.4 |
| 34 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 51.4 |
| 35 | Upstate Cancer CenterSyracuse, NY Active Research Program | 51.4 |
| 36 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 51.4 |
| 37 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 51.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →